description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TGGTAACTGTAGGGGCCTTTTTTGCTAGCAAGTGAGAAAGTCTAGGGCCAGGTGGGGCTAGGTGTGGCTAGGGGCCAGGAGAGCTGGAACAATAGCGAATGCCCTTGGAAGAAACTGGATGGTCACGGAACAGAGAAAGGCAGGGGAAGGTAGTGTGTGTGGGAGCCCAGCATGCCAGGCAGGTGGCAGGGAGAATGAGTTGGAAACATTAAGGAATGTTTCAAGGCCAAGAACCCAGAGAGTGGAGTCATCCCACGGCTTGGGGGGTGGGGGTGGGGAGGTGGGAGGAATCATGCCCATATCGCGGGCACACAACTACCCGGAACATGGCTTGTAGCTCCAAGGACGGTGAGCTTACTTCAAAGATCTGTGTCTCGACTAGATGAATGGGATTTAGGGAGCCTAGAATTCACTTCCCTTTGGGATGGAAGCTTGGTGATCAGG
Ensembl | mouse accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
mouse ... BCL2L2(12050), Bcl2l2(12050)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Hyun Joo Chung et al.
Oncotarget, 6(21), 18429-18444 (2015-07-15)
Glioblastoma multiforme (GBM) is the most common malignant brain tumor and exhibits aggressive and invasive behavior. We previously identified four miRNAs-miR-29b, 494, 193a-3p, and 30e-with enhanced expression in GBM following treatment of ionizing radiation by miRNA microarray analysis. In this
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EMU021461-50UG | 04061828280087 |
| EMU021461-20UG | 04061828505128 |